TY - JOUR
T1 - The effects of hypertension on the paediatric brain
T2 - A justifiable concern
AU - Sharma, Madhu
AU - Kupferman, Juan C.
AU - Brosgol, Yuri
AU - Paterno, Kara
AU - Goodman, Sharon
AU - Prohovnik, Isak
AU - Kirkham, Fenella J.
AU - Pavlakis, Steven G.
N1 - Funding Information:
SGP and JCK received support from Maimonides Research Foundation, and MS (with SGP) received support from Empire State Clinical Trials Fellowship. FJK was funded by the Wellcome Trust. The funding sources had no role in this report. We thank Jason Macdonald, Southampton University Hospitals NHS Trust, for providing the images in figure 2 .
PY - 2010/9
Y1 - 2010/9
N2 - The prevalence of hypertension in children is increasing but its neurological effects are under-recognised. Here, we describe acute and chronic effects of childhood hypertension on the nervous system. Acute neurological involvement ranges from posterior reversible encephalopathy syndrome to, possibly, infarction and haemorrhage. Children with chronic hypertension are likely to have learning disabilities and deficiencies in executive function, which are potentially reversible with antihypertensive treatment. These cognitive defects may be secondary to abnormal regulation of cerebral blood flow. Raised blood pressure in childhood could also contribute to the early development of atherosclerosis, which can have both short-term and long-term adverse effects on vasculature. Clinical studies are needed to better define the full clinical range of paediatric hypertension on a child's nervous system. Furthermore, accurate biomarkers to define cognitive abnormalities and cerebral involvement need to be identified.
AB - The prevalence of hypertension in children is increasing but its neurological effects are under-recognised. Here, we describe acute and chronic effects of childhood hypertension on the nervous system. Acute neurological involvement ranges from posterior reversible encephalopathy syndrome to, possibly, infarction and haemorrhage. Children with chronic hypertension are likely to have learning disabilities and deficiencies in executive function, which are potentially reversible with antihypertensive treatment. These cognitive defects may be secondary to abnormal regulation of cerebral blood flow. Raised blood pressure in childhood could also contribute to the early development of atherosclerosis, which can have both short-term and long-term adverse effects on vasculature. Clinical studies are needed to better define the full clinical range of paediatric hypertension on a child's nervous system. Furthermore, accurate biomarkers to define cognitive abnormalities and cerebral involvement need to be identified.
UR - http://www.scopus.com/inward/record.url?scp=77955662357&partnerID=8YFLogxK
U2 - 10.1016/S1474-4422(10)70167-8
DO - 10.1016/S1474-4422(10)70167-8
M3 - Comment/debate
C2 - 20675195
AN - SCOPUS:77955662357
SN - 1474-4422
VL - 9
SP - 933
EP - 940
JO - The Lancet Neurology
JF - The Lancet Neurology
IS - 9
ER -